Ajay Sharma

Dr. Ajay Sharma

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
DKDharambir Kashyap
Dharambir Kashyap
HTHardeep Singh Tuli
Hardeep Singh Tuli
Mükerrem Betül YererMükerrem Betül Yerer
Mükerrem Betül Yerer
ASAjay Sharma
Ajay Sharma
Katrin SakKatrin Sak
Katrin Sak
Anupam BishayeeAnupam Bishayee
Anupam Bishayee

1 March 2017 in Journal of Functional Foods
Verified
Journal Article
Closed access
DKDharambir Kashyap
Dharambir Kashyap
ASAjay Sharma
Ajay Sharma
HTHardeep Singh Tuli
Hardeep Singh Tuli
Katrin SakKatrin Sak
Katrin Sak
SPSandeep Punia
Sandeep Punia
TMTapan K. Mukherjee
Tapan K. Mukherjee

9 September 2016 in Recent Patents on Inflammation & Allergy Drug Discovery
Verified
Journal Article
Closed access
DKDharambir Kashyap
Dharambir Kashyap
ASAjay Sharma
Ajay Sharma
HTHardeep Singh Tuli
Hardeep Singh Tuli
SPSandeep Punia
Sandeep Punia
ASAnil Kumar Sharma
Anil Kumar Sharma
Background: Plant derived products are not only served as dietary components but also used to treat and prevent the inflammatory associated diseases like cancer. Among the natural products pentacyclic terpenoids including ursolic acid and oleanolic acid are considered as the promising anti-inflammatory therapeutic agents. Objectives: The current review extensively discusses the anti-inflammatory therapeutic potential of these pentacyclic moieties along with their proposed mechanisms of action. Furthermore, the relevant patents have also been listed to present the health benefits of these promising therapeutic agents to pin down the inflammatory diseases. Expert opinion: Pentacyclic terpenoids are known to negatively down-regulate a variety of extracellular and intracellular molecular targets associated with disease progression. The major anti-inflammatory effects of these molecules have been found to be mediated via inactivation of NF, STAT3/6, Akt/mTOR pathways. A number of patents on UA & OA based moieties have been reported between 2010 and 2016. Still there have been only a few compounds which meet the need of sufficient hydro solubility and bioavailability along with higher anti-inflammatory activities. Thus, it is essential to develop novel derivatives of terpenpoids which may not only overcome the solubility issues but also may improve their therapeutic effects. In addition, scientific community may utilize nanotechnology based drug delivery systems so as to increase the bio-availability, selectivity and dosages related problems.

1 February 2018 in Life Sciences
Verified
Journal Article
Closed access
DKDharambir Kashyap
Dharambir Kashyap
ASAjay Sharma
Ajay Sharma
Katrin SakKatrin Sak
Katrin Sak
HTHardeep Singh Tuli
Hardeep Singh Tuli
HBHarpal Singh Buttar
Harpal Singh Buttar
Anupam BishayeeAnupam Bishayee
Anupam Bishayee

4 December 2019 in Recent Patents on Inflammation & Allergy Drug Discovery
Verified
Journal Article
Open access
PDF file
ACAshun Chaudhary
Ashun Chaudhary
VJVivek Sheel Jaswal
Vivek Sheel Jaswal
SCSonika Choudhary
Sonika Choudhary
SOSonika
Sonika
ASAjay Sharma
Ajay Sharma
SSSanjeev Sharma
Sanjeev Sharma
Background: Among the various phenolics metabolites, ferulic acid is considered as the promising mitigating, restorative and antioxidant agent. Ferulic acid is one of the most commonly found natural products in vegetables, for example, tomatoes, sweet corn, and in rice grain. Phytochemicals are utilized in the treatment of human ailments and these are derived from the dietary compounds. Objective: The present review widely argued the calming restorative capability of ferulic acid alongside the scientific evidences and its proposed mechanism for activity. Furthermore, we provided the main practical points for the use of ferulic acid in oxidative damages during various diseases. Additionally, the relevant patents on ferulic acid with various therapeutic potential has been discussed. Methods: One hundred and twenty references have been cited in the present review article. The cited references were found to be suitable and described the therapeutic application of ferulic acid thoroughly. Conclusion: Ferulic acids are known to contrarily down-manage an assortment of extracellular and intrcelullular molecular targets related to infection movement. Various patents on ferulic acid based moieties have been accounted for from 2018. The ferulic acids have a wide scope of impacts against different infections like malignant growth, diabetes, cardiovascular and neurodegenerative diseases. The current review deals with the antioxidant property of ferulic acid and the recent patent describes the role of ferulic acid against human diseases.

1 August 2018 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
DKDharambir Kashyap
Dharambir Kashyap
ASAjay Sharma
Ajay Sharma
HTHardeep Singh Tuli
Hardeep Singh Tuli
Katrin SakKatrin Sak
Katrin Sak
TMTapan Mukherjee
Tapan Mukherjee
Anupam BishayeeAnupam Bishayee
Anupam Bishayee